First Horizon Advisors’s Immunomedics Inc IMMU Stock Holding History

First Horizon Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,831	Closed	-$155K	–	1630
2020 Q3	$155K	Hold	1,831	–	–	0.01%	337
2020 Q2	$64K	Hold	1,831	–	–	0.01%	470
2020 Q1	$23K	Hold	1,831	–	–	﹤0.01%	689
2019 Q4	$38K	Buy	1,831 +504	+38%	+$8.89K	﹤0.01%	646
2019 Q3	$17K	Hold	1,327	–	–	﹤0.01%	912
2019 Q2	$18K	Hold	1,327	–	–	﹤0.01%	910
2019 Q1	$24K	Buy	+1,327	New	+$21.4K	﹤0.01%	777

First Horizon Advisors's IMMU Position: Q4 2020 in Review

First Horizon Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,831 shares — an estimated $155K sold.

First Horizon Advisors first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $155K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

First Horizon Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
First Horizon Advisors sold 1,831 Immunomedics Inc shares in Q4 2020, an estimated $155K.
First Horizon Advisors first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
First Horizon Advisors's Immunomedics Inc position peaked at $155K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on First Horizon Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.